Confidential · Legal Agreement

Non-Disclosure & Intellectual Property Protection Agreement

ForLife Global Ltd

1. Introduction & Scope

1.1 Purpose of the Agreement

This Non-Disclosure and Intellectual Property Protection Agreement (“Agreement”) establishes the legally binding terms under which ForLife Global Ltd (“ForLife”) safeguards its confidential information, trade secrets, intellectual property, proprietary technologies, and business strategies. The purpose of this Agreement is to:

Ensure the confidentiality of all sensitive business, technical, financial, and strategic information shared between ForLife and any parties bound by this Agreement.

Define ownership rights over all intellectual property developed, disclosed, or used in connection with ForLife’s business operations.

Prohibit unauthorised use, disclosure, reproduction, or distribution of confidential information and proprietary assets.

Protect ForLife’s competitive advantage by restricting the creation of competing products or services, unauthorised partnerships, or direct engagement with ForLife’s stakeholders.

Establish clear enforcement mechanisms in case of breach, ensuring that ForLife can seek legal remedies, financial compensation, and injunctive relief if its confidential information or intellectual property is misused.

This Agreement is non-negotiable and applies universally to all individuals and entities engaging with ForLife’s confidential information.

1.2 Scope of Confidentiality & Intellectual Property Protections

This Agreement extends to all information, materials, and intellectual property disclosed, developed, or utilised by ForLife, including but not limited to:

Confidential Information, including internal business strategies, technical designs, research data, financial records, partner contracts, proprietary algorithms, and trade secrets.

Intellectual Property (IP), including patents, trademarks, copyrights, branding, proprietary software, AI models, blockchain protocols, and any inventions created within ForLife’s ecosystem.

Third-Party Information received by ForLife under separate confidentiality obligations, including client and partner data, business agreements, and regulatory documentation.

Unregistered IP & Future Innovations, ensuring that all newly developed technologies, processes, or methodologies related to ForLife automatically fall under this Agreement.

Restricted Activities, explicitly prohibiting reverse engineering, data mining, AI model training using ForLife’s data, unauthorised research, or technology reproduction.

This Agreement applies regardless of the method of disclosure (written, verbal, digital, physical, or otherwise) and extends to all data, discussions, contracts, prototypes, and systems connected to ForLife’s operations.

1.3 Parties Bound by the Agreement

This Agreement applies to all individuals and entities with access to ForLife’s confidential information or intellectual property, including but not limited to:

Employees, Contractors, & Advisors – Any person working for or advising ForLife in any capacity, including full-time, part-time, remote, freelance, or consultancy arrangements.

Business Partners & Investors – Any individual, company, or entity involved in negotiations, joint ventures, funding discussions, or strategic partnerships with ForLife.

Clients & Service Providers – Any external organisation or professional engaged to provide services, technology, consultancy, or support to ForLife.

Vendors, Suppliers, & Manufacturers – Any third-party involved in the production, development, or supply of ForLife’s proprietary technology, branding materials, or operational tools.

Research Institutions & Collaborators – Any academic, governmental, or private research organisation conducting projects in collaboration with ForLife.

Regulatory Bodies & Auditors – Where applicable, regulatory entities and compliance bodies granted limited access to certain confidential materials under strict legal obligations.

All parties bound by this Agreement must ensure that their employees, subcontractors, and affiliates also comply with the terms of confidentiality and intellectual property protection. Failure to enforce internal compliance does not exempt an entity from liability under this Agreement.

1.4 Duration of Agreement & Long-Term Protections

This Agreement remains legally binding for the following durations:

For Employees, Contractors, & Advisors: Confidentiality and IP obligations continue for the duration of their engagement with ForLife and remain enforceable for a period of [insert duration, e.g., five years] post-termination, with indefinite restrictions on proprietary technology.

For Business Partners, Clients, & Third-Parties: Confidentiality protections apply indefinitely, with intellectual property ownership restrictions remaining enforceable permanently.

For Investments, Mergers, or Acquisitions: If ForLife undergoes a merger, acquisition, or sale, all obligations under this Agreement automatically transfer to the successor entity.

For Future Patents & Intellectual Property: All innovations, trademarks, and technologies developed under this Agreement fall under its protections indefinitely, preventing any competing claims or retroactive disputes.

ForLife reserves the right to extend, modify, or reinforce this Agreement as required to maintain the security of its confidential information and intellectual property rights. Any changes to the Agreement will be automatically enforceable for all bound parties upon notification.

2. Definitions of Confidential Information & Intellectual Property

2.1 Definition of "Confidential Information"

For the purposes of this Agreement, Confidential Information refers to any non-public, proprietary, or sensitive data, materials, or insights disclosed by or relating to ForLife Global Ltd (“ForLife”), including but not limited to:

Business & Strategic Information – Internal business plans, market analysis, financial data, investment strategies, product roadmaps, and partnership negotiations.

Technical & Development Information – Software architecture, source code, algorithms, database structures, blockchain applications, AI models, product specifications, prototypes, and research data.

Operational & Process Information – Internal workflows, supply chain data, vendor agreements, standard operating procedures, and automation frameworks.

Marketing & Branding Materials – Unreleased campaigns, advertising strategies, website development plans, and proprietary market research.

Client & Partner Information – Contracts, correspondence, business dealings, health sector affiliations, and regulatory compliance strategies.

Legal & Compliance Documentation – Regulatory filings, intellectual property applications, patent disclosures, trade secret documentation, and risk assessments.

Investor & Financial Agreements – Private financial reports, funding negotiations, valuation models, equity structures, and capital investment terms.

Confidential Information includes any discussions, negotiations, or documentation shared verbally, digitally, or physically, regardless of whether it is explicitly marked as confidential.

2.2 Definition of "Intellectual Property"

ForLife retains full ownership of all Intellectual Property (IP), including but not limited to:

Patents & Patent Applications – Registered and unregistered innovations, proprietary methodologies, and future patent filings.

Trademarks & Branding Elements – Corporate identity, logos, product names, visual designs, and marketing assets.

Copyrighted Materials – Written content, reports, digital assets, website content, and creative works associated with ForLife’s brand.

Trade Secrets & Proprietary Knowledge – Unique business methodologies, data analysis frameworks, and strategic processes.

Software & Digital Platforms – ForLife’s technology stack, mobile applications, API frameworks, AI-driven health solutions, and blockchain-based security systems.

Research & Development Outputs – Unreleased technologies, product iterations, and confidential testing data.

All intellectual property created, developed, or improved in relation to ForLife is considered exclusive company property, regardless of whether it was developed in collaboration with external parties.

2.3 Definition of "Prohibited Uses"

Confidential Information and Intellectual Property covered by this Agreement may not be used for any purpose other than the intended business relationship with ForLife. Prohibited uses include but are not limited to:

Copying, sharing, or distributing confidential materials without explicit authorisation from ForLife.

Reverse engineering or attempting to recreate any ForLife technology, software, or proprietary methods.

Training AI models or machine learning systems using ForLife’s data, research insights, or user interactions.

Developing or supporting competing products, services, or business models using knowledge obtained from ForLife.

Publishing, disclosing, or using any ForLife data for commercial, research, or personal gain without prior written consent.

Engaging in business transactions, partnerships, or financial arrangements based on privileged ForLife information.

Any breach of these prohibited uses will result in immediate legal action, including but not limited to financial damages, injunctive relief, and termination of all business agreements.

2.4 Information Exclusions

This Agreement does not apply to information that:

Was lawfully obtained from a third party without obligations of confidentiality.

Was publicly available at the time of disclosure or later became public without breach of this Agreement.

Was independently developed without reliance on ForLife’s proprietary knowledge.

Must be disclosed due to legal or regulatory requirements, provided that ForLife is given advance notice and the opportunity to contest the disclosure where permitted by law.

All exclusions must be proven with documented evidence to prevent misuse of confidential protections.

3. Confidentiality Obligations

3.1 Duty to Protect & Maintain Confidentiality

All parties bound by this Agreement are obligated to protect and maintain the confidentiality of ForLife Global Ltd’s proprietary information. This duty extends to employees, contractors, consultants, investors, and any third parties granted access to confidential materials.

The Receiving Party must:

Exercise strict care and diligence in safeguarding Confidential Information.

Use Confidential Information solely for the purposes of the business relationship with ForLife.

Prevent unauthorised copying, sharing, or access to confidential documents, discussions, or digital data.

Ensure that employees, contractors, and partners comply with this Agreement, including signing separate NDAs where required.

Failure to uphold confidentiality obligations will constitute a material breach, triggering immediate enforcement actions, including legal and financial remedies.

3.2 Permitted Disclosures & Restrictions on Third-Party Access

Confidential Information may only be disclosed under the following permitted circumstances:

Internal disclosure within the Receiving Party’s organisation is allowed, but only on a need-to-know basis and with prior approval from ForLife.

Legal or regulatory obligations where disclosure is required by law, provided that ForLife receives prompt written notice and is given the opportunity to contest or limit the disclosure.

Authorised third-party collaborations explicitly approved by ForLife in writing, with recipients subject to equally binding confidentiality agreements.

The Receiving Party must not:

Disclose Confidential Information to competitors, unauthorised investors, or external stakeholders without written consent.

Allow employees, consultants, or contractors to access Confidential Information without ensuring they are subject to similar obligations.

Share, license, or repurpose ForLife’s proprietary data for external business ventures or personal gain.

Any unauthorised disclosure, even if unintentional, triggers immediate legal and financial consequences.

3.3 Security Measures & Data Handling Requirements

To ensure strict security of Confidential Information, the Receiving Party must implement industry-standard security protocols, including but not limited to:

Access Control: Confidential Information should only be accessible to pre-authorised individuals with unique, role-based credentials.

Encryption & Secure Storage: All digital confidential materials must be encrypted using industry-standard security protocols (AES-256 encryption, SSL/TLS transmission, multi-factor authentication).

Physical Security: Printed documents, prototypes, or hardware containing Confidential Information must be stored in secured, restricted-access locations.

Data Segmentation: Confidential Information must not be stored on shared, public, or unsecured cloud storage without explicit approval from ForLife.

Audit Trails & Monitoring: Access to confidential digital assets must be logged and monitored for suspicious activity.

ForLife retains the right to audit compliance with security protocols and request immediate corrective actions where necessary.

3.4 Reporting & Mitigation of Unauthorised Disclosure

If the Receiving Party becomes aware of any unauthorised disclosure, data leak, or breach, they must:

Immediately notify ForLife in writing with full details of the incident.

Assist ForLife in containing and mitigating any potential damage.

Take immediate remedial action to prevent further unauthorised disclosures.

Cooperate fully with forensic investigations, legal proceedings, or regulatory reporting as required by ForLife.

Failure to report or mitigate a breach will escalate liability and may result in:

Financial damages proportional to the harm caused.

Injunctions or cease-and-desist orders against further disclosure.

Criminal liability, where applicable under data protection laws.

3.5 Exclusions & Safe Harbours

The obligations outlined in this Agreement do not apply to information that:

Becomes publicly available without any breach of this Agreement.

Is independently developed without reference to ForLife’s Confidential Information.

Is disclosed by a third party legally and without obligation of confidentiality.

Is required to be disclosed by law, provided that ForLife is notified in advance to limit exposure where possible.

ForLife retains the right to request documentary evidence proving an exclusion applies before recognising any exemption from confidentiality obligations.

3.6 Restrictions on AI Model Training, Data Mining & Web Scraping

ForLife strictly prohibits the use of its Confidential Information, Intellectual Property, and operational data for:

AI Model Training: No part of ForLife’s data, discussions, or proprietary content may be used to train, refine, or develop AI models, machine learning systems, or generative technologies.

Data Mining & Automated Extraction: The Receiving Party may not scrape, collect, or analyse ForLife’s data using bots, automated scripts, or data extraction tools.

Derivative AI Tools or Platforms: No ForLife-owned or related data may be incorporated into AI-driven healthcare solutions, analytics tools, or blockchain verification models without explicit approval.

No part of ForLife’s data, discussions, proprietary content, or business methodologies may be used to train, refine, or develop AI models, machine learning systems, or generative technologies—even if anonymised. The Receiving Party is also prohibited from engaging in AI-assisted analysis of ForLife’s proprietary datasets, including pattern recognition, trend analysis, or metadata extrapolation.

Any unauthorised AI usage or data extraction will be considered intellectual property theft and will be pursued legally and financially, including injunctive relief and damages.

4. Intellectual Property Ownership & Protection

4.1 ForLife’s Full Ownership Over All IP Assets

ForLife Global Ltd retains exclusive and full ownership over all Intellectual Property (IP) created, developed, or utilised within its business operations, including but not limited to:

Patents & Inventions – All proprietary technologies, algorithms, and software solutions, whether granted or pending.

Trademarks & Branding – All logos, brand names, service marks, trade dress, and other branding elements associated with ForLife.

Copyrights & Original Works – Any written, visual, or digital content, including software code, documentation, reports, marketing materials, and product designs.

Trade Secrets & Confidential Know-How – Any proprietary methodologies, frameworks, strategic plans, business models, and operational processes unique to ForLife.

Data & Analytical Models – Any healthcare data models, AI-driven insights, and analytics that contribute to ForLife’s service offerings.

Ownership over all existing and future IP assets remains solely with ForLife Global Ltd. No external party may claim or infer ownership over any proprietary material related to ForLife.

4.2

Work-for-Hire & Automatic Assignment of IP Created for ForLife

All work produced by employees, contractors, consultants, or third-party developers on behalf of ForLife Global Ltd is classified as Work-for-Hire, ensuring that ForLife retains full ownership over all resulting intellectual property.

Automatic Assignment Clause: Any Intellectual Property created, developed, improved, or modified while working under ForLife’s directives is automatically assigned to ForLife, without the need for further action.

Moral Rights Waiver: The Receiving Party agrees to waive any moral or authorship rights over any work created for ForLife, ensuring full control over modifications, adaptations, or derivative works.

No Residual Rights: The Receiving Party has no ongoing claim, entitlement, or future stake in the IP, regardless of their contribution to its development.

Employee & Contractor Compliance: All employees and contractors must execute separate IP assignment agreements reaffirming their obligations under this section.

ForLife retains sole ownership over all intellectual property, including any contributions made by external collaborators, research institutions, or third-party developers, unless explicitly stated otherwise in a separate written agreement. Any AI-generated content, algorithms, or machine learning outputs derived from ForLife’s proprietary data or systems shall be deemed ForLife’s exclusive property. The Receiving Party waives all claims to co-ownership, regardless of their level of contribution.

Failure to comply with these terms may result in legal claims, injunctive relief, and financial damages to recover ForLife’s exclusive rights.

4.3 Restrictions on Use, Licensing, or Copying of ForLife’s Technology

The Receiving Party must not, under any circumstances:

Replicate, reverse-engineer, or decompile ForLife’s software, platforms, or proprietary technology.

License, sublicense, or transfer any part of ForLife’s Intellectual Property to any third party without explicit written consent.

Modify, alter, or create derivative works based on ForLife’s proprietary technology.

Use ForLife’s technology or trade secrets for competitive advantage, product development, or any unauthorised business activity.

Sell, lease, or exploit ForLife’s Intellectual Property, methodologies, or internal processes for commercial gain.

Any violation of these restrictions will constitute intellectual property theft and contractual breach, triggering immediate enforcement actions, including financial damages and legal injunctions.

4.4 No Rights or Claims Granted to the Receiving Party

This Agreement does not:

Grant any rights, licenses, or entitlements to the Receiving Party over ForLife’s Intellectual Property.

Establish any form of joint ownership over proprietary works, regardless of contributions.

Allow implied use of ForLife’s patents, copyrights, trade secrets, or proprietary data beyond the scope of authorised business engagements.

The Receiving Party acknowledges that they:

Hold no legal, equitable, or beneficial interest in ForLife’s Intellectual Property.

Cannot claim authorship, inventorship, or co-ownership of any proprietary work created under ForLife’s directives.

Have no rights to challenge, contest, or interfere with ForLife’s patent filings, copyright claims, or brand registrations.

Failure to adhere to these restrictions will be treated as an intellectual property infringement, enforceable under civil and criminal law.

4.5 Protection of Unregistered IP & Future Patent Rights

ForLife asserts ownership rights over all current and future intellectual property, including:

Pending patents & unpublished inventions – Ensuring that all proprietary developments, whether registered or not, remain under ForLife’s exclusive control.

Unregistered trademarks, trade dress, and branding elements – Including logos, service marks, and any unique brand identifiers that are in use but not yet formally registered.

Future innovations, modifications, and derivatives – Any enhancements or iterations of ForLife’s existing IP automatically belong to ForLife, regardless of the personnel involved in their development.

AI, algorithms, and machine learning models – Ensuring all AI-generated insights, automated processes, and analytical frameworks remain proprietary to ForLife.

The Receiving Party agrees that:

They will not register, file, or attempt to claim IP rights over any ForLife-related innovations.

They will not oppose, contest, or challenge any future patents, trademarks, or copyrights filed by ForLife.

They must disclose any innovations, discoveries, or improvements made using ForLife’s Confidential Information or Intellectual Property, which will automatically be assigned to ForLife.

Any unauthorised claim or attempt to exploit ForLife’s unregistered IP will be treated as fraudulent misappropriation, resulting in legal action and financial penalties.

Top of Form

Bottom of Form

5. Non-Compete & Non-Circumvention

This section establishes binding restrictions on the Receiving Party to prevent unfair competition, unauthorised business dealings, and the misuse of confidential information for self-benefit or competitive advantage.

5.1 Restriction on Creating Competing Products or Services

The Receiving Party agrees that they:

Shall not develop, manufacture, distribute, sell, or provide any product, service, or technology that competes directly or indirectly with ForLife Global Ltd.

Shall not initiate, invest in, advise, or support any third party in the development of a competing platform, service, or technology.

Are prohibited from repurposing, adapting, or modifying ForLife’s Intellectual Property, trade secrets, or confidential information to create a competing or derivative product.

Must not work with, consult, or assist any competitor in any way that could provide an unfair advantage against ForLife.

These restrictions shall remain in effect for a period of three 6 years following termination of engagement, employment, or contractual relationship with ForLife. If the Receiving Party has had access to proprietary technology, AI models, or patent-protected processes, this period shall extend to five 8 years where enforceable by law.

5.2 Ban on Using Confidential Information for Competitive Advantage

The Receiving Party agrees:

Not to use, disclose, or exploit any of ForLife’s Confidential Information in a way that benefits a competitor or disadvantages ForLife.

Not to apply ForLife’s proprietary strategies, methodologies, or market insights to develop or enhance competing services, businesses, or technologies.

Not to engage in strategic business activities using ForLife’s operational, financial, or technological knowledge for personal or third-party gain.

Any misuse of Confidential Information for competitive advantage will be classified as misappropriation of trade secrets, enforceable under civil and criminal law.

5.3 Restriction on Direct Engagement with ForLife’s Partners, Clients, and Stakeholders

The Receiving Party shall not, without explicit written consent from ForLife Global Ltd:

Engage in any business dealings with ForLife’s existing or prospective clients, partners, investors, or affiliates.

Solicit, negotiate, or enter into contracts with any party introduced through ForLife, either directly or indirectly.

Bypass ForLife in transactions or agreements involving proprietary technology, business models, or collaborative initiatives.

Induce, persuade, or attempt to disrupt ForLife’s existing or future relationships with third parties.

This restriction remains in force for [X] years after termination of the Receiving Party’s involvement with ForLife.

Any violation of this clause will constitute tortious interference, resulting in compensatory damages, injunctive relief, and reputational liability.

5.4 Geographic & Time-Based Scope of Non-Compete Restrictions

The non-compete restrictions apply:

Globally, with a focus on markets where ForLife operates or intends to expand.

For a period of 6 years post-engagement, to prevent immediate exploitation of ForLife’s proprietary knowledge.

Regardless of whether the Receiving Party acts independently or through a third party (including affiliates, shell entities, or associates).

The non-compete restrictions shall apply for the following durations, unless otherwise modified by law:

General non-compete: Six (6) years after termination of engagement with ForLife.

Access to core technology & trade secrets: Eight (8) years post-engagement.

High-level executives, R&D teams, and proprietary AI developers: Ten (10) years where enforceable by law.

If a court determines that the time-period is excessive, the parties agree that the maximum enforceable duration shall automatically apply in its place.

The timeframe and geographic restrictions may be extended if evidence of malicious intent, bad faith, or circumvention is discovered.

5.5 Permissible Business Activities Outside of ForLife’s Scope

To clarify, the Receiving Party may engage in:

Independent business ventures that do not compete with ForLife’s solutions, services, or strategic goals.

Consulting or advisory roles that do not involve ForLife’s Confidential Information, trade secrets, or IP.

Employment or contractual work with companies that are not direct or indirect competitors of ForLife.

However, if there is any doubt about competitive overlap, the Receiving Party must obtain ForLife’s written consent before proceeding.

6.1 Prohibition on Publicly Discussing ForLife’s Business Operations Without Consent

The Receiving Party shall not, under any circumstances:

Make public statements, comments, or disclosures regarding ForLife’s internal operations, business strategies, financial status, partnerships, or proprietary technologies without explicit, written authorisation.

Discuss, publish, or share information related to ForLife’s ongoing projects, innovations, client engagements, or corporate strategies on any public platform, including social media, forums, conferences, or networking events.

Disclose trade secrets, confidential methodologies, or strategic developments, even if such discussions are presented as industry commentary, research, or personal insights.

This prohibition applies during the term of engagement and indefinitely thereafter, ensuring continued protection of ForLife’s market position.

Any violation of this clause will be treated as a material breach, subject to legal action, financial penalties, and reputational damages.

6.2 Restrictions on Using ForLife’s Name, Logo, or Brand for Personal or Business Gain

The Receiving Party shall not use ForLife’s branding, trademarks, or corporate identity in any way that:

Implies endorsement, affiliation, or sponsorship where none exists.

Is intended to promote personal, professional, or third-party business interests.

Creates confusion, misrepresentation, or unauthorised association with ForLife.

Specifically, the Receiving Party is prohibited from:

Displaying ForLife’s name, logo, trademarks, or visual branding on any website, promotional material, or media without formal approval.

Using ForLife’s identity or reputation to solicit business, gain credibility, or secure partnerships.

Registering, purchasing, or controlling domain names, social media accounts, or online properties that incorporate ForLife’s branding or likeness.

Any unauthorised use of ForLife’s branding constitutes trademark infringement and reputational harm, subject to legal recourse, injunctive relief, and damages.

6.3 Confidentiality of Business Relationships & Negotiations

The Receiving Party must uphold strict confidentiality regarding all business relationships, negotiations, and partnerships involving ForLife, including:

Discussions, agreements, or transactions with clients, investors, or affiliates, regardless of whether they have been publicly announced.

Negotiations, deal structures, investment terms, or strategic partnerships, even if agreements have not been finalised.

Third-party collaborations, licensing agreements, or joint ventures, ensuring that competitive advantage is preserved.

The Receiving Party must not:

Divulge the existence, nature, or terms of ForLife’s business relationships to any external party.

Use insider knowledge of ForLife’s negotiations to gain a competitive edge or to interfere with deals in any manner.

Facilitate or leak information that could alter stock valuation, investor confidence, or partnership credibility.

Breach of this clause will result in immediate legal action, including compensatory damages, injunctive relief, and contract termination.

6.4 Handling of Media Inquiries or Public Statements

The Receiving Party is strictly prohibited from making any public statements on behalf of ForLife, responding to media inquiries, or engaging in interviews that reference ForLife Global Ltd., unless:

Explicit written approval is granted by ForLife’s executive management or legal team.

A designated spokesperson or PR representative is appointed to handle the matter.

Statements are pre-approved, reviewed, and align with ForLife’s official communication strategy.

If approached by media, press, or external parties requesting information about ForLife, the Receiving Party must not engage and instead:

Refer all inquiries to ForLife’s legal or PR department.

Decline to comment or confirm any details regarding ForLife’s operations, financials, or corporate matters.

Avoid speculation, opinions, or informal remarks that could be construed as an official position.

Failure to comply with these media restrictions will result in legal liability, reputational damage claims, and possible termination of business engagement.

7. Non-Solicitation of ForLife Employees & Business Partners

This section establishes clear restrictions on poaching, solicitation, and interference with ForLife’s workforce, client base, and business partnerships. These clauses ensure business stability, protect ForLife’s investments in relationships, and prevent unfair competitive practices.

7.1 Ban on Poaching ForLife Employees, Contractors, or Consultants

The Receiving Party agrees that during their engagement with ForLife and for a period of [X] years thereafter, they shall not directly or indirectly:

Recruit, hire, or attempt to hire any individual currently employed or contracted by ForLife, regardless of whether they are engaged on a full-time, part-time, freelance, or consultancy basis.

Induce or encourage any ForLife employee, consultant, or contractor to terminate their relationship with ForLife.

Facilitate employment discussions, make offers, or provide referrals to ForLife personnel for competing opportunities within the same or a related industry.

To prevent competitive harm, the Receiving Party shall not, directly or indirectly, engage or recruit more than one (1) former ForLife employee within a twelve (12) month period without ForLife’s written approval. Any mass hiring effort targeting ForLife’s workforce shall be considered a breach of this Agreement, entitling ForLife to seek injunctive relief and financial damages.

This restriction applies globally and covers both direct solicitation and indirect attempts, such as engaging third parties, recruiters, or business affiliates to initiate contact on behalf of the Receiving Party.

Breach of this provision will result in immediate legal action, financial penalties equivalent to lost business value, and possible injunctive relief.

7.2 Prohibition on Soliciting or Diverting ForLife’s Clients or Business Partners

The Receiving Party shall not, under any circumstances, use their knowledge of ForLife’s business operations, clientele, or strategic partners to:

Solicit, approach, or attempt to engage any of ForLife’s existing or prospective clients, investors, business partners, or affiliates for a competing product, service, or business venture.

Encourage any entity that has a business relationship with ForLife to modify, reduce, or terminate its engagement with ForLife.

Divert contracts, projects, investments, or business development opportunities that were intended for or originated from ForLife.

This restriction extends to all commercial relationships, including technology partnerships, distribution networks, strategic alliances, and supplier contracts.

Violation of this clause will be deemed intentional business interference, entitling ForLife to monetary damages, loss recovery compensation, and injunctive relief to prevent further harm.

7.3 Duration & Scope of Non-Solicitation Clause

To ensure enforceability while maintaining fairness, the restrictions under this section will apply for:

A minimum period of [X] years following termination of engagement with ForLife.

Global enforcement, preventing solicitation activities regardless of jurisdiction.

All business relationships that ForLife had at the time of the Receiving Party’s engagement, as well as those established during the restriction period.

The time period and geographic scope may be subject to local enforceability regulations, but ForLife retains the right to extend these protections through renewed agreements, business contracts, or legal amendments.

Failure to comply will result in liability for all resulting business losses, including projected revenue impact, reputational harm, and legal fees associated with enforcement.The Receiving Party agrees that non-solicitation restrictions shall remain in effect for:

Three 5 years for employees, contractors, or consultants after their departure from ForLife.

Five 8 years for clients, investors, business partners, or stakeholders after the termination of the business relationship with ForLife.

If ForLife discovers an indirect attempt to solicit, such as through an intermediary or third-party company, the timeframe resets from the date of discovery.

The Receiving Party acknowledges that ForLife has developed significant goodwill with its clients, partners, and employees. To prevent unfair exploitation of this goodwill, non-solicitation restrictions shall remain in force for five (5) years following termination. The Receiving Party agrees that these terms are necessary to protect ForLife’s legitimate business interests and do not impose an undue restraint of trade.

7.4 Exceptions & Pre-Existing Business Relationships

The following limited exceptions apply to this clause:

If a business relationship with a ForLife client, employee, or contractor existed prior to the Receiving Party’s engagement with ForLife, and there is clear, documented evidence of such a relationship.

If ForLife provides explicit, written consent permitting engagement with a specific individual or entity.

If the engagement is non-competitive and does not involve direct solicitation, business interference, or the promotion of rival services or technologies.

The burden of proof rests on the Receiving Party to demonstrate that any engagement does not breach the terms of this clause.

7.5 Restrictions on Indirect Solicitation (Through Affiliates or Third Parties)

The Receiving Party shall not attempt to circumvent the restrictions in this section by engaging in indirect solicitation methods, including:

Using intermediaries, recruiters, or affiliated entities to approach ForLife’s employees, clients, or business partners on their behalf.

Encouraging mutual acquaintances, colleagues, or professional contacts to initiate discussions or relay business offers to ForLife-associated individuals or companies.

Investing in, partnering with, or financially supporting a competing entity that then solicits ForLife’s business relationships on their behalf.

The Receiving Party shall not engage in indirect solicitation by:

Using intermediaries, recruiters, shell entities, or affiliated companies to approach ForLife’s employees, clients, or business partners.

Facilitating introductions between competitors and ForLife’s business relationships.

Investing in, financing, or otherwise supporting a competing entity that then engages in solicitation.

Any attempt to bypass these protections will be treated as a direct violation, with forensic review of digital communications, financial transactions, and business engagements used as evidence in legal proceedings.

Enforcement & Legal Recourse

To ensure compliance, ForLife retains the right to:

✔ Monitor engagements involving former employees, contractors, and business affiliates for potential breaches.✔ Issue cease-and-desist notices if solicitation or poaching attempts are detected.✔ Seek financial damages for each violation, including lost revenue, operational disruptions, and reputational harm.✔ Pursue injunctive relief to prevent further engagement with ForLife’s personnel or business partners.

Any breach will be subject to immediate enforcement under Section 9: Liability, Enforcement & Legal Remedies.

8. Handling, Return, & Destruction of Confidential Information

This section defines the protocols for securely storing, accessing, returning, and disposing of confidential materials. It establishes clear measures for data security, breach response, and compliance with privacy regulations, ensuring that ForLife’s proprietary information is never misused, leaked, or retained beyond authorised periods.

8.1 Secure Storage, Access, and Security of Confidential Materials

The Receiving Party agrees to implement industry-leading security measures to protect all confidential information received from ForLife, including:

Secure Physical & Digital Storage – Confidential documents must be stored in encrypted digital environments or locked physical locations with restricted access.

Access Control & User Authentication – Only authorised personnel with a legitimate need-to-know basis may access confidential information.

Data Encryption – All sensitive files, databases, and communication channels must be encrypted using at least AES-256 encryption for stored data and TLS 1.3 encryption for data in transit.

Multi-Factor Authentication (MFA) – Secure logins and restricted access must be enforced for all systems handling ForLife’s confidential information.

Audit Trails & Access Logs – All access attempts, modifications, and transmissions of confidential data must be recorded and monitored for unauthorised activity.

Data Anonymisation Where Possible – If applicable, sensitive data should be pseudonymised or anonymised to minimise exposure risks.

Failure to adhere to these security standards will be considered gross negligence and a material breach of this agreement, subject to legal enforcement under Section 9: Liability, Enforcement & Legal Remedies.

8.2 Mandatory Return or Certified Destruction of Information Upon Termination

Upon termination or expiration of engagement with ForLife, the Receiving Party must immediately:

Return all physical and digital copies of ForLife’s confidential information in their possession.

Cease access to, use of, or reference to any proprietary data derived from ForLife’s intellectual property.

Certify in writing that all confidential information has been securely deleted or destroyed from systems, backups, and external storage devices.

Provide documented proof of data deletion or destruction, including records of secure file shredding, database purging, or digital wiping (using methods such as DoD 5220.22-M standard or equivalent).

All confidential materials, including digital files, printed documents, and backups, must be returned or permanently destroyed within thirty (30) days of termination of engagement.

ForLife retains the right to audit compliance with data destruction requirements up to twelve 48 months after termination.

If legal or regulatory obligations require longer retention periods, the Receiving Party must notify ForLife and comply with applicable privacy laws, including GDPR and HIPAA.

ForLife reserves the right to conduct third-party audits or require forensic verification of proper compliance with data return and destruction policies.

Retention of any confidential material beyond the termination period, whether intentionally or due to negligence, will be treated as intellectual property theft, subject to immediate enforcement.

8.3 Procedures for Handling Data Breaches or Unauthorised Use

If a data breach, security incident, or unauthorised access to ForLife’s confidential information occurs, the Receiving Party must:

Notify ForLife immediately (within 24 hours) upon discovering the incident.

Provide a full report detailing the nature, scope, and potential impact of the breach.

Take immediate remedial actions to contain, isolate, and mitigate further damage.

Cooperate fully with ForLife’s security team, forensic investigators, and legal representatives to assess and address the breach.

Comply with regulatory reporting requirements under GDPR, HIPAA, PDPA, and other applicable privacy laws.

If a data breach occurs due to negligence or failure to meet security obligations, the Receiving Party shall be fully liable for:

All financial penalties imposed by data protection authorities.

The cost of ForLife’s forensic investigation, legal defence, and crisis management.

Compensation to affected parties, including clients and stakeholders.

Any reputational damage or lost business resulting from the breach.

ForLife retains the right to terminate the agreement, seek financial damages, and pursue legal action in cases where the breach results from gross negligence, security failures, or deliberate misconduct.

Additionally, if the Receiving Party fails to report a breach or attempts to conceal a security incident, they will be held fully liable for all regulatory penalties, financial losses, and reputational harm caused by the incident.

8.4 Digital Security Measures (Encryption, Access Logs, Multi-Factor Authentication)

To prevent unauthorised access and ensure compliance with best security practices, the Receiving Party must:

Encrypt all sensitive files and communications using military-grade encryption protocols.

Enable role-based access control (RBAC) to restrict data visibility based on user roles.

Use secure authentication protocols, including biometrics, hardware tokens, or MFA for all confidential data access.

Maintain a digital access log that tracks every user interaction with ForLife’s confidential materials.

Implement automated intrusion detection systems (IDS) and anomaly detection to identify and prevent potential breaches.

ForLife reserves the right to audit security policies of any Receiving Party handling its confidential data to ensure full compliance with these measures.

Failure to enforce digital security protocols will be considered gross negligence, resulting in legal consequences.

8.5 Data Retention & Expiry Protocols

To ensure compliance with global privacy laws and data minimisation principles, the Receiving Party agrees to:

Retain confidential information only for the minimum period necessary to fulfil contractual obligations.

Ensure automatic deletion or anonymisation of data once its intended purpose has been served.

Implement structured data lifecycle policies, including scheduled reviews and secure archival where necessary.

Permanently erase all non-essential confidential data upon completion of a project, regulatory requirement, or business necessity.

ForLife may request periodic compliance reports verifying adherence to data retention policies. Any unauthorised or indefinite retention of confidential materials beyond permitted timelines will be considered a breach of contract.

Enforcement & Legal Recourse

ForLife retains the right to:

Conduct third-party security audits to verify compliance.

Issue immediate termination notices if security obligations are violated.

Seek full compensation for financial, operational, and reputational damages caused by non-compliance.

Pursue legal action in multiple jurisdictions if confidential data is mishandled, leaked, or misused.

Any breach of this section will be escalated under Section 9: Liability, Enforcement & Legal Remedies.

9. Liability, Enforcement & Legal Remedies

This section outlines the legal consequences of breaching this Agreement, including financial damages, injunctive relief, and liability for intellectual property theft, data breaches, or business interference. ForLife retains the right to enforce strict penalties, seek compensation for losses, and take immediate legal action against any party that violates the terms of confidentiality, non-compete, intellectual property, or data security obligations.

9.1 Consequences of Breaching the Agreement (Financial Damages & Injunctive Relief)

If a party breaches this Agreement, they shall be liable for liquidated damages, in addition to actual damages incurred. If a court finds the liquidated damages amount unenforceable, the maximum legally enforceable penalty shall apply:

Financial Damages: The breaching party shall be liable for direct, indirect, and consequential damages caused to ForLife, including loss of business, reputational harm, regulatory penalties, and lost profits.

Injunctive Relief: ForLife has the right to seek an immediate court-ordered injunction to prevent further disclosure, misuse, or continuation of the breach. This applies to IP theft, unauthorised distribution, or any violation that could cause irreparable harm.

Termination of Agreement & Revocation of Access: ForLife may immediately terminate the contract and revoke all access rights to its technology, systems, or confidential materials.

Liquidated Damages Clause (If Applicable): If pre-agreed damages are specified within a contract (e.g., a predetermined penalty for violating confidentiality terms), the breaching party must pay the stated sum in full.

Reputational Consequences: If the breach results in negative publicity, legal proceedings, or regulatory scrutiny, the responsible party shall bear all associated damages, including PR crisis management and legal defence costs.

ForLife reserves the right to escalate enforcement to international courts if the breach involves multiple jurisdictions.

9.2 Right to Seek Immediate Legal Action & Recovery of Losses

ForLife retains the unrestricted right to take immediate legal action against any party that violates this Agreement. This includes, but is not limited to:

Filing lawsuits for intellectual property theft, contract breach, or data privacy violations.

Seizing assets or freezing accounts through court orders to recover stolen property or compensate for damages.

Compelling the breaching party to disclose all individuals or entities who have accessed or benefitted from unauthorised use of ForLife’s confidential information.

Pursuing criminal charges where applicable, particularly in cases of fraud, data theft, or cybercrime.

Any legal action initiated under this Agreement shall be enforceable in the jurisdictions specified in Section 10: Governing Law & Dispute Resolution.

9.3 Court Orders, Compensation, and Recovery of Legal Fees

To deter breaches and ensure strict enforcement, ForLife reserves the right to:

Obtain court orders mandating the destruction of misappropriated data and the cessation of competitive activities resulting from unauthorised use of ForLife’s proprietary information.

Recover all legal fees, court costs, and investigation expenses incurred in enforcing this Agreement.

Claim compensation for lost revenue, market value reduction, and competitive disadvantage arising from a breach.

Compel restitution from third parties who have gained from the misuse of ForLife’s intellectual property or confidential data.

If the breach results in industry violations, data privacy fines (under GDPR, HIPAA, PDPA, or similar regulations), or regulatory investigations, the responsible party shall be solely liable for all associated penalties and financial liabilities.

9.4 Liability for Data Leaks, IP Violations, or Business Interference

If a party mishandles ForLife’s confidential information, trade secrets, or intellectual property, they shall bear full legal and financial liability for:

Data Leaks & Cybersecurity Breaches: The breaching party shall cover all damages arising from leaks of personal, financial, or proprietary data, including compensation to affected parties, regulatory fines, and forensic security audits.

Intellectual Property Violations: Any unauthorised reproduction, reverse engineering, or commercial exploitation of ForLife’s patents, trademarks, copyrights, or proprietary algorithms shall be met with legal action for infringement, including demands for royalties and cessation of use.

Business Interference & Competitive Harm: If a breach enables a third party to compete unfairly using ForLife’s confidential methodologies, market insights, or trade secrets, the responsible party shall compensate for lost business opportunities, investor damages, and partner trust erosion.

ForLife shall enforce monetary damages, legal orders, and third-party liability claims against any individual or entity that facilitates or benefits from unauthorised access or use of its assets.

9.5 Indemnification Clause – Protection Against Third-Party Claims

The Receiving Party agrees to indemnify, defend, and hold harmless ForLife Global Ltd, its officers, directors, employees, contractors, investors, and affiliates from and against all claims, damages, liabilities, and expenses arising from:

Misuse, disclosure, or theft of confidential information.

Violation of data protection laws (including GDPR, HIPAA, PDPA, and other regulatory frameworks).

Legal actions initiated by third parties due to security failures, breaches, or misuse of ForLife’s proprietary technology.

Financial penalties, settlements, or damages incurred due to unauthorised use of ForLife’s brand, logo, trademarks, or intellectual property.

If ForLife is sued or held legally liable due to the Receiving Party’s actions or negligence, the Receiving Party shall:

Cover all legal defence costs, settlement amounts, and court-ordered penalties.

Reimburse ForLife for any losses resulting from reputational harm, regulatory scrutiny, or operational setbacks.

Take full responsibility for remediating the harm caused, including issuing public clarifications, engaging in corrective actions, and assisting in damage control efforts.

This indemnification obligation survives the termination of this Agreement and remains enforceable indefinitely.

Enforcement & Legal Recourse

To ensure maximum protection and compliance, ForLife reserves the right to:

Blacklist or bar future partnerships with any entity or individual found to have breached this Agreement.

Demand forensic IT audits to verify compliance with data destruction, access restrictions, and security protocols.

Issue cease-and-desist orders against parties engaging in unauthorised use of ForLife’s intellectual property.

Take preemptive legal action, including injunctions and asset freezes, against any party suspected of violating this Agreement.

Any breach of this section will be escalated under Section 10: Governing Law & Dispute Resolution, and ForLife will enforce all available remedies to the fullest extent permissible by law.

The Receiving Party shall also indemnify ForLife against any reputational harm caused by unauthorised disclosures, including the cost of crisis communications, legal defences, and lost business opportunities resulting from reputational damage.

10. Governing Law & Dispute Resolution

This Agreement shall be governed by and enforced in accordance with the laws most favourable to ForLife Global Ltd, ensuring maximum protection for its intellectual property, confidential information, and business interests.

10.1 Jurisdiction & Applicable Legal Framework

This Agreement is governed by the laws of [Insert Primary Jurisdiction], with enforceability in all regions where ForLife operates or holds intellectual property rights.

In the event of a legal conflict, the laws that provide the strongest protections for ForLife’s business, IP, and trade secrets shall take precedence.

Applicable statutes include, but are not limited to:

UK Data Protection Act 2018, UK Copyright, Designs and Patents Act 1988

Australian Corporations Act 2001 & Privacy Act 1988

Thailand Personal Data Protection Act (PDPA) & Business Regulations

EU General Data Protection Regulation (GDPR), where applicable

Cross-border enforcement shall be recognised under the New York Convention (1958) on the enforcement of foreign arbitral awards.

In the event of a conflict between legal jurisdictions, the laws that provide the highest level of protection for ForLife’s Confidential Information and Intellectual Property shall take precedence. The Receiving Party agrees that they shall not contest the jurisdiction of the courts specified by ForLife for dispute resolution.

10.2 Binding Arbitration & Dispute Resolution Process

Any dispute, controversy, or claim arising out of or in connection with this Agreement shall be resolved exclusively through binding arbitration under the rules of [Insert Arbitration Body: ICC, LCIA, SIAC].

The arbitration shall take place in [Insert Jurisdiction], and proceedings shall be conducted in English.

Arbitration rulings shall be final, binding, and enforceable in all jurisdictions where ForLife has legal interests.

The party against whom the arbitration ruling is made shall bear all associated costs, legal fees, and compensatory damages.

10.2.1 Expedited Injunctive Relief

ForLife reserves the right to seek immediate injunctive relief (court order) in any jurisdiction to prevent irreparable harm, including but not limited to:

Breach of confidentiality or misuse of trade secrets

Unauthorised use, distribution, or disclosure of proprietary technology

IP violations, data breaches, or regulatory infractions

Such relief shall not delay or preclude arbitration but shall serve to prevent immediate competitive harm or financial damage to ForLife.

The losing party in any arbitration or legal dispute under this Agreement shall bear all arbitration, court, and legal costs incurred by the prevailing party. If a partial ruling is granted, cost allocation shall be determined proportionally by the arbitrator or court.

10.3 Enforcement Across Multiple Jurisdictions

This Agreement shall be enforceable in all jurisdictions where ForLife operates, holds assets, or maintains intellectual property rights.

Courts in any signatory nation to the New York Convention on Recognition and Enforcement of Foreign Arbitral Awards (1958) shall recognise and uphold arbitration rulings.

ForLife retains the right to select the most favourable jurisdiction for enforcement, ensuring the maximum recovery of damages and legal remedies.

10.4 Confidentiality of Dispute Resolution

All arbitration, mediation, and legal proceedings arising under this Agreement shall be strictly confidential.

The Receiving Party is prohibited from disclosing any details regarding disputes, including:

Legal filings, arbitration proceedings, or settlement discussions

Any reference to ForLife’s dispute resolution process in media, investor reports, or industry communications

Breach of this confidentiality provision shall result in:

Immediate termination of any business relationship

Pre-determined liquidated damages of [Insert Amount]

Permanent injunctive relief preventing further disclosures

10.5 Class Action Waiver & Individual Legal Resolution

The Receiving Party waives the right to participate in any class-action lawsuit, mass arbitration, or multi-party litigation against ForLife.

All claims must be resolved on an individual basis through arbitration or legal proceedings in ForLife’s chosen jurisdiction.

Any attempt to circumvent this waiver shall result in immediate dismissal of the claim, and the offending party shall be held liable for ForLife’s legal costs.

10.6 Final Enforcement & Remedies

ForLife Global Ltd retains the exclusive right to:

Determine the most advantageous legal strategy for dispute resolution.

Pursue immediate injunctive relief, asset freezes, and emergency enforcement actions.

Collaborate with regulatory bodies for cross-border compliance and legal enforcement.

Enforce this Agreement without waiving any future rights or claims.

Failure by ForLife to enforce any provision shall not constitute a waiver of its rights to enforce it in the future.

11. Data Protection & Compliance with Privacy Laws

ForLife Global Ltd is committed to upholding the highest data protection and privacy standards, ensuring full compliance with global regulations while safeguarding confidential information, intellectual property, and sensitive business data.

11.1 Compliance with GDPR, UK Data Protection Act, HIPAA, PDPA, and Australian Privacy Act

The Receiving Party must fully comply with all applicable data protection laws, including but not limited to:

General Data Protection Regulation (GDPR) (EU & UK)

UK Data Protection Act 2018

Health Insurance Portability and Accountability Act (HIPAA) (US healthcare-specific compliance)

Thailand Personal Data Protection Act (PDPA)

Australian Privacy Act 1988

ForLife retains the right to update its compliance framework in response to changes in legal, regulatory, or industry standards.

If a conflict arises between applicable data protection laws, the strictest standard shall apply, ensuring maximum privacy protection.

11.1.1 Compliance Monitoring & Periodic Audits

ForLife reserves the right to conduct compliance audits, verifying that the Receiving Party adheres to all data security, access control, and privacy protection measures.

Failure to comply with audit requirements may result in:

Immediate termination of agreements and partnerships.

Legal action to recover damages resulting from non-compliance.

Referral to relevant regulatory authorities for enforcement action.

11.2 Restrictions on Storing, Using, or Transferring Confidential or Personal Data

The Receiving Party is strictly prohibited from storing, processing, or transferring any confidential or personal data obtained through its association with ForLife unless explicitly authorised.

Storage & Access Limitations:

Data must be stored only within secure environments that meet ForLife’s encryption and access control standards.

No unauthorised duplication, reproduction, or local storage of ForLife’s confidential data is permitted.

Cross-Border Data Transfer Restrictions:

Any international transfer of personal or confidential data requires ForLife’s prior written approval.

The Receiving Party must ensure compliance with cross-border data transfer mechanisms, such as GDPR-approved Standard Contractual Clauses (SCCs), Binding Corporate Rules (BCRs), or other legally recognised frameworks.

No Third-Party Data Access:

Confidential data may not be shared, sold, licensed, or otherwise transferred to any external entity, including subsidiaries, affiliates, or data brokers, without ForLife’s explicit authorisation.

11.2.1 Consequences of Unauthorised Data Use

Immediate termination of business relationships with full legal recourse.

Regulatory reporting and enforcement action by data protection authorities.

Monetary damages payable by the Receiving Party, including fines imposed by regulatory bodies due to non-compliance.

11.3 Data Breach Response & Legal Obligations

In the event of a data breach, unauthorised access, or security incident, the Receiving Party must:

Notify ForLife immediately (within 24 hours of discovery) via ForLife’s designated security contact.

Provide a detailed incident report, including:

Nature of the breach

Data affected

Scope and impact assessment

Immediate mitigation actions taken

Cooperate fully with ForLife’s cybersecurity and legal teams in conducting forensic investigations.

Implement corrective security measures as directed by ForLife within a legally binding remediation period.

Comply with all applicable breach notification laws, including GDPR’s 72-hour breach reporting requirement and any national-level disclosure obligations.

11.3.1 Liability for Data Breaches

If the Receiving Party’s actions or negligence lead to a data breach, financial penalty, or regulatory sanction, they shall be fully liable for:

All associated costs, including forensic investigations, legal fees, and remediation expenses.

Compensation to affected individuals or businesses.

Fines imposed by data protection authorities.

The Receiving Party shall indemnify ForLife against all claims, lawsuits, and enforcement actions arising from their failure to protect confidential or personal data.

11.4 Cross-Border Data Transfers & Compliance with Regional Laws

Any transfer of personal or confidential data across national borders must:

Comply with the data protection laws of the originating country.

Be explicitly authorised by ForLife in writing.

Use legally recognised data transfer frameworks (e.g., GDPR SCCs, BCRs, or equivalent mechanisms).

The Receiving Party is responsible for ensuring compliance with foreign data protection laws when handling information outside of ForLife’s primary jurisdiction.

If a conflict arises between the laws of different jurisdictions, the strictest applicable data protection standard must be applied.

11.4.1 Data Localisation & Storage Requirements

If applicable laws mandate local data storage (e.g., Thailand’s PDPA or China’s CSL), the Receiving Party must:

Store data only in government-approved, secure data centres.

Ensure local compliance with encryption, access control, and retention policies.

Restrict access to authorised personnel only, with full audit logs maintained.

11.5 Data Minimisation & Purpose-Limitation Principles

ForLife enforces a strict data minimisation policy, ensuring that:

The Receiving Party only collects, processes, or accesses the minimum necessary data required to fulfil their obligations under this Agreement.

Personal and confidential data must not be repurposed, monetised, or used for analytics, AI training, or non-authorised functions.

The Receiving Party must justify the necessity of data access, and any excessive data collection shall be deemed a violation of this Agreement.

The Receiving Party may only retain confidential data for the minimum period necessary to fulfil contractual obligations, and under no circumstances beyond twelve (12) months post-termination unless required by law.

Any retained data must be securely archived with restricted access, encryption, and automatic deletion schedules.

Unauthorized retention or failure to erase confidential data within the defined timeframe will constitute a breach of this Agreement, subject to enforcement under Section 9 (Liability, Enforcement & Legal Remedies).

11.5.1 Prohibition on AI Model Training & Data Monetisation

The Receiving Party is explicitly prohibited from using ForLife’s data to train artificial intelligence models, conduct predictive analytics, or develop derivative products without ForLife’s written consent.

Any attempt to monetise, sell, or commercially exploit ForLife’s confidential data shall result in:

Immediate termination of agreements

Legal claims for financial damages and IP infringement

Permanent injunctive relief preventing further misuse

12. Duration & Survival of Obligations

12.1

Timeframe for Confidentiality, Non-Compete, and IP Protections

This Agreement establishes long-term protections to ensure the security of ForLife’s intellectual property, business operations, and confidential information.

Confidentiality Obligations – All confidentiality obligations shall remain in force for ssix (6) years following the termination or expiration of this Agreement, unless a longer duration is mandated by applicable law or contractual extensions.

Intellectual Property Protections – All IP, including trade secrets, proprietary methodologies, software, algorithms, and technology created for or provided by ForLife, shall remain perpetually protected under this Agreement.

Non-Compete Restrictions – Any non-compete restrictions shall remain enforceable for the timeframe and geographical scope outlined in Section 5, ensuring that recipients of confidential information do not engage in competitive activities that could harm ForLife’s business interests.

Confidentiality obligations shall remain in effect for a minimum of six (6) years following termination of engagement with ForLife.

For proprietary technology, AI models, and intellectual property, these protections shall be indefinite and shall continue until such information enters the public domain through no fault of the Receiving Party.

Trade secrets remain protected indefinitely unless lawfully disclosed or independently developed without reliance on ForLife’s proprietary knowledge.

Indefinite Protections:

Confidentiality obligations concerning trade secrets, proprietary technologies, and undisclosed research shall remain enforceable indefinitely, or until such information enters the public domain through no fault of the receiving party.

All intellectual property developed under this Agreement remains exclusively owned by ForLife in perpetuity.

For proprietary technology, AI models, and intellectual property, these protections shall be indefinite and shall continue until such information enters the public domain through no fault of the Receiving Party. Trade secrets, proprietary methodologies, and internal business strategies shall also remain protected indefinitely.

12.2 Clauses That Remain Enforceable After Agreement Termination

The expiration or termination of this Agreement does not release the parties from their legal obligations regarding:

Intellectual Property Rights & Ownership – The receiving party shall have no claim to ForLife’s IP after termination, and all rights remain solely with ForLife.

Confidentiality & Non-Disclosure – The duty to protect confidential information shall continue for six (6) years post-termination, with perpetual protection for trade secrets.

Non-Solicitation & Non-Circumvention – Restrictions on engaging with ForLife’s partners, clients, or employees remain in effect as specified in Section 7, even after contract termination.

Indemnification for Breach – The receiving party remains fully liable for any violations of this Agreement, regardless of whether the Agreement is still active at the time of discovery.

Liability for Data Breach or IP Infringement – If a breach or unauthorised disclosure occurs after termination but originated from information accessed under this Agreement, the violating party remains legally accountable.

12.3 Renewal & Extension of Agreement Terms

This Agreement automatically renews sixty (60) days before expiration unless written notice of termination is provided by either party at least ninety (90) days in advance.

Any renegotiation of terms must be initiated at least ninety (90) days prior to the expiration date to allow for contract adjustments while ensuring uninterrupted confidentiality and IP protection.

If no renegotiation occurs, the existing terms shall remain in full effect, ensuring continuity of protections.

12.4 Expiration of Specific Obligations & Exceptions

While the Agreement enforces strict protections, the following specific exceptions apply:

Regulatory Compliance & Data Retention – ForLife shall adhere to global data protection laws, ensuring proper retention and destruction of personal data as required under GDPR, HIPAA, PDPA, and other applicable regulations.

Publicly Available or Independently Developed Information – If confidential information legally enters the public domain or is independently developed without reliance on ForLife’s proprietary assets, related obligations may expire earlier.

Regulatory Obligations for Record Keeping – If applicable laws require longer retention of certain records for audit, regulatory, or compliance purposes, the parties shall abide by such requirements.

12.5 Effect of Business Closure or Acquisition on NDA Obligations

In the event ForLife undergoes a merger, acquisition, or change in control, this Agreement shall remain fully binding upon the acquiring entity, which shall be required to reaffirm all existing NDA obligations.

If the receiving party ceases operations, all confidentiality, non-compete, and IP obligations shall remain legally enforceable against its successors, assigns, or legal representatives.

If ForLife discontinues its business entirely, protections related to trade secrets, proprietary technology, and confidential data shall remain in effect for as long as necessary to prevent the unauthorised use, transfer, or commercialisation of its assets.

13. Compliance with Future Patents & IP Registrations

13.1 Protection of Future ForLife Patents, Trademarks & Proprietary Technologies

ForLife Global retains full ownership and control over all future intellectual property, including but not limited to:

Patents – Any future patents, pending applications, or proprietary inventions developed by or for ForLife.

Trademarks & Branding – Any future trade names, logos, or brand assets registered under ForLife.

Copyrights – All future creative works, marketing materials, software, and documentation.

Trade Secrets & Proprietary Information – Internal methodologies, algorithms, product strategies, and research data.

Emerging Technologies – Any AI-driven, blockchain-integrated, or other technological advancements created under or affiliated with ForLife.

The receiving party shall not claim, register, or attempt to commercialise any intellectual property that originates from ForLife, whether it is disclosed during or after the term of this Agreement.

13.2 Prohibition on Challenging Future IP Applications

To ensure the integrity and security of ForLife’s innovation pipeline:

The receiving party agrees not to contest, oppose, or challenge any future patent, trademark, or copyright applications filed by ForLife.

If the receiving party becomes aware of competing filings or potential infringements, they are legally required to notify ForLife immediately and assist in protecting ForLife’s intellectual property rights.

Any attempts to register, publish, or use ForLife’s proprietary ideas, technologies, or branding in a way that could create conflicting ownership claims will be considered a direct breach of this Agreement and subject to legal enforcement.

13.3 Automatic Inclusion of New Inventions, Processes, & Innovations

Any new inventions, improvements, or technological advancements developed by or for ForLife during the duration of this Agreement shall be automatically included within the scope of its protected intellectual property.

If the receiving party collaborates or contributes to ForLife’s product development, all resulting work shall be assigned to ForLife as its exclusive intellectual property.

The receiving party waives any future claims to ownership of contributions, irrespective of whether they were made directly, indirectly, voluntarily, or under a separate contract.

13.4 Prevention of IP Dilution or Conflicting Use

To safeguard ForLife’s brand identity, proprietary technologies, and business strategies, the receiving party shall not engage in activities that could lead to:

IP Dilution – Any unauthorised use, imitation, or modification of ForLife’s branding or trademarks in a way that weakens their distinctiveness.

Conflicting Product Offerings – The development, licensing, or sale of any technology, service, or product that directly competes with or mimics ForLife’s proprietary assets.

Parallel Business Ventures – The use of ForLife’s trade secrets, designs, or methodologies to launch similar businesses, platforms, or technologies.

All protections against dilution, misappropriation, and conflicting use shall remain enforceable indefinitely to prevent unfair competition or reputational harm.

13.5 Obligations for Disclosing Related Innovations (Employee & Contractor Contributions)

Employees, contractors, and partners must promptly disclose any discoveries, modifications, or innovations that relate to, build upon, or integrate with ForLife’s existing or future intellectual property.

All such contributions are automatically assigned to ForLife, ensuring its continued legal ownership and exclusive commercialisation rights.

The receiving party must execute all necessary documents to formally assign rights and assist in securing patents, trademarks, or other protections.

If an employee or contractor develops an independent invention that may intersect with ForLife’s business, they must disclose it for evaluation to determine if it falls under this Agreement.

14. Acquisition, Business Transfers & Change of Control

14.1 NDA Obligations Continue Under New Ownership

In the event of a merger, acquisition, public listing, or any other change of control involving ForLife, all terms and obligations under this Agreement shall remain binding on all parties. Successor entities acquiring ForLife must assume full responsibility for upholding the confidentiality, intellectual property protections, and non-compete clauses contained herein. Similarly, any change in control of the Receiving Party shall not affect its obligations under this Agreement. No transfer of ownership shall relieve either party from its obligations to protect Confidential Information and Intellectual Property as outlined in this Agreement.

In the event ForLife undergoes a merger, acquisition, or restructuring, all NDA obligations shall automatically transfer to the successor entity, which must reaffirm and uphold the Agreement in full. If the successor fails to do so, all proprietary assets and confidential materials shall revert to ForLife’s original owners or designated trustees.

14.2 Requirement for Successors to Reaffirm NDA Terms

As a condition of any business transfer or corporate restructuring, the acquiring entity must expressly agree in writing to assume and adhere to all obligations under this Agreement. ForLife shall ensure that any agreement governing a change of control includes a provision requiring the successor entity to execute a legally binding reaffirmation of all NDA terms. Likewise, if the Receiving Party undergoes a change in ownership or control, it must ensure that its successor entity agrees in writing to be bound by this NDA. Until such reaffirmation is executed, the original parties remain fully liable for any breaches of confidentiality.

14.3 Restrictions on Transferring Confidential Information to Acquiring Entities

ForLife shall not disclose, transfer, or permit access to any Confidential Information to any potential acquiring entity, investor, or merger partner unless they have entered into a confidentiality agreement that meets or exceeds the protections outlined in this Agreement. The Receiving Party is also prohibited from sharing or transferring any ForLife Confidential Information to any acquiring entity without ForLife’s prior written consent. Any attempt to transfer, assign, or disclose Confidential Information as part of a business asset sale is strictly prohibited unless expressly authorised in writing by ForLife.

If the Receiving Party is acquired by a competitor or an entity that engages in a similar business, ForLife reserves the right to terminate this Agreement immediately and demand the return or destruction of all Confidential Information. The Receiving Party must notify ForLife in writing at least sixty (60) days prior to any such acquisition to allow ForLife to assess potential conflicts of interest and take protective measures.

14.4 Rights of ForLife to Modify or Strengthen NDA Terms Upon Business Transfer

ForLife retains the right to amend or strengthen the confidentiality terms of this Agreement in anticipation of or in conjunction with a business transfer, acquisition, or corporate restructuring. These amendments may include extending the duration of confidentiality obligations, restricting access to proprietary technologies, or imposing new compliance measures to address evolving risks. Any amendment under this clause shall be formally communicated to the Receiving Party, and the successor entity must agree in writing to any additional protections required by ForLife to ensure the continued safeguarding of Confidential Information and Intellectual Property.

14.5 Preventing Unauthorised Takeover & Protection of Intellectual Property

The Receiving Party shall not use any Confidential Information obtained under this Agreement to pursue an unsolicited or hostile acquisition of ForLife. Any such action is expressly prohibited unless explicitly invited by ForLife in writing. Furthermore, in the event that an external entity, particularly a competitor, attempts to acquire the Receiving Party in a manner that could expose ForLife’s Confidential Information or Intellectual Property, ForLife reserves the right to take preemptive protective actions. These actions may include exercising a right of first refusal, reclaiming previously shared Intellectual Property, or implementing additional legal safeguards to prevent unauthorised disclosure. These provisions ensure that ForLife’s trade secrets, proprietary technology, and strategic assets remain secure from external threats, preserving its competitive advantage and autonomy.

15. Miscellaneous Provisions

15.1 No Waiver of Rights or Enforcement (Failure to Enforce Does Not Invalidate Agreement)

The failure or delay of ForLife to enforce any provision of this Agreement shall not be considered a waiver of its rights to enforce the same or any other provision in the future. Any waiver must be explicitly agreed to in writing by an authorised representative of ForLife. A one-time waiver of any breach shall not constitute a waiver of any subsequent or continuing breach of the same or different provisions.

15.2 Severability of Individual Clauses (If One Clause is Invalid, Others Remain Binding)

If any provision of this Agreement is found to be invalid, illegal, or unenforceable under applicable law, such provision shall be deemed modified to the extent necessary to make it enforceable while preserving its intent. If modification is not possible, the provision shall be severed from the Agreement, and the remaining provisions shall continue in full force and effect. The invalidity of one section shall not affect the enforceability of the rest of the Agreement.

15.3 Entire Agreement Clause (Superseding Prior NDAs & Agreements)

This Agreement constitutes the entire understanding between ForLife and the Receiving Party regarding the subject matter herein. It supersedes all prior agreements, discussions, negotiations, or understandings, whether written or oral, relating to confidentiality, intellectual property, and the obligations herein. Any modifications, amendments, or supplements must be agreed to in writing and signed by both parties.

15.4 No Automatic Assignment of Rights Without Written Approval

The Receiving Party may not assign, delegate, or transfer any of its rights or obligations under this Agreement without ForLife’s prior written consent. Any attempted assignment, delegation, or transfer in violation of this provision shall be null and void. ForLife, however, retains the right to assign its rights and obligations under this Agreement to a successor entity in the event of a corporate restructuring, provided that such successor entity assumes all obligations under this Agreement.

15.5 Non-Relinquishment of ForLife’s Intellectual Property & Confidentiality Rights

Nothing in this Agreement shall be construed as relinquishing ForLife’s ownership, control, or rights over its Confidential Information or Intellectual Property. Any unauthorised attempt to claim, file patents on, or use ForLife’s proprietary information for independent commercial gain shall be deemed a material breach of this Agreement, subject to legal enforcement.

15.6 Force Majeure – Exemptions in Case of Natural Disasters, War, or Governmental Acts

Neither party shall be held liable for failure to perform any obligations under this Agreement if such failure is due to circumstances beyond its reasonable control, including but not limited to acts of God, war, terrorism, civil unrest, government restrictions, natural disasters, pandemics, or other force majeure events. The affected party must notify the other party as soon as practicable and take reasonable steps to mitigate the impact of such an event. The obligations under this Agreement shall resume as soon as the force majeure event ceases to prevent performance.

15.7 Electronic Signatures & Digital Acknowledgment Validity

This Agreement may be executed and accepted electronically, including through e-signature platforms, email confirmations, or any other legally recognised digital acknowledgment system. Electronic signatures and digitally acknowledged agreements shall have the same legal validity and enforceability as manually signed agreements. The Receiving Party agrees that continued access to ForLife’s Confidential Information and Intellectual Property shall serve as an ongoing reaffirmation of the obligations set forth in this Agreement.

Section 16: Miscellaneous Provisions

16. Miscellaneous Provisions16.1 No Waiver of Rights or Enforcement. The failure or delay of either party to exercise any right, power, or remedy under this Agreement shall not constitute a waiver of that right or remedy. Any waiver of any provision or right under this Agreement must be made in writing and signed by the waiving party. A waiver on one occasion shall not be interpreted as a waiver of any other provision or of the same provision on any other occasion.

16.2 Severability of Individual Clauses. If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, that provision shall be severed from the Agreement. The remaining provisions of this Agreement shall remain in full force and effect and continue to be binding. If feasible, the parties agree to replace any invalid or unenforceable provision with a valid provision that most closely achieves the intent and economic effect of the original provision.

16.3 Entire Agreement (Superseding Prior Agreements). This Agreement constitutes the entire understanding between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous agreements, negotiations, and communications, whether written or oral, relating to the same subject matter. No amendment or modification of this Agreement shall be valid unless it is made in writing and signed by both parties. Each party acknowledges that it is not relying on any representation, warranty, or assurance that is not expressly set forth in this Agreement.